Proper diagnosis is paramount as several highly-prescribed MS treatments (eg, glatiramer acetate, interferon β (IFN-β), fingolimod, and dimethyl fumarate) can worsen conditions for people with NMO or MOG-ADs [17,31,32]. This evidence concerns the gene MOG and neuromyelitis optica.